Clinical Trials List
Protocol NumberEMRP62110N
Not yet recruiting
2021-12-01 - 2024-11-30
Phase I/II
Terminated1
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
18 participants
-
Global
0 participants
